| Product NDC: | 10019-653 |
| Proprietary Name: | SEVOFLURANE |
| Non Proprietary Name: | Sevoflurane |
| Active Ingredient(s): | 250 mL/250mL & nbsp; Sevoflurane |
| Administration Route(s): | RESPIRATORY (INHALATION) |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 10019-653 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075895 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020707 |
| Package NDC: | 10019-653-64 |
| Package Description: | 6 BOTTLE in 1 CARTON (10019-653-64) > 250 mL in 1 BOTTLE |
| NDC Code | 10019-653-64 |
| Proprietary Name | SEVOFLURANE |
| Package Description | 6 BOTTLE in 1 CARTON (10019-653-64) > 250 mL in 1 BOTTLE |
| Product NDC | 10019-653 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Sevoflurane |
| Dosage Form Name | LIQUID |
| Route Name | RESPIRATORY (INHALATION) |
| Start Marketing Date | 20020707 |
| Marketing Category Name | ANDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | SEVOFLURANE |
| Strength Number | 250 |
| Strength Unit | mL/250mL |
| Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |